Novo Nordisk A/S (NVO)
38.58
+0.62
(+1.63%)
USD |
NYSE |
Mar 16, 16:00
38.46
-0.12
(-0.31%)
Pre-Market: 06:14
Novo Nordisk Market Cap : 171.43B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 14.18B |
| Evaxion AS | 31.86M |
| Regeneron Pharmaceuticals, Inc. | 80.02B |
| Viking Therapeutics, Inc. | 4.161B |
| DBV Technologies SA | 1.119B |
Market Cap Related Metrics
| PE Ratio | 11.12 |
| PS Ratio | 3.674 |
| PEG Ratio | 1.970 |
| Price to Book Value | 7.411 |
| Price to Free Cash Flow | 39.02 |
| Price | 38.58 |
| Earnings Yield | 8.99% |
| PEGY Ratio | 1.099 |
| Operating PE Ratio | 8.923 |
| Normalized PE Ratio | 11.12 |